Dilyana Filipova, Wolfgang Boomgaarden, Leyla Fox, et al. Need for NAMs: A systematic evidence synthesis revealing over half a century of drug development failure. NAM Journal. 2026:100119. doi:10.1016/j.namjnl.2026.100119
Judith C. Madden, Steven J. Enoch, Alicia Paini, Mark T.D. Cronin. Redefining the gold standard and recommendations to accelerate the adoption of New Approach Methodologies (NAMs) in support of the Three Rs. Alternatives to Laboratory Animals. 2026;54(2):85-100. doi:10.1177/02611929261423850
Fernando Pardo-Manuel de Villena, James M. Amos-Landgraf, Timothy A. Bell, et al. Improve genetic quality control to increase rigor and reproducibility of mouse research. Science. 2026;392(6799):698-700. doi:10.1126/science.aec3177
Hamideh Frühwein, Norbert W. Paul. “Lost in translation?” Animal research in the era of precision medicine. Journal of Translational Medicine. 2025;23(1):152. doi:10.1186/s12967-025-06084-3
Alexis R. Katz, Margaret P. Huntwork, Jay K. Kolls, et al. Impact of psychological stressors on natural killer cell function: A comprehensive analysis based on stressor type, duration, intensity, and species. Physiology & Behavior. 2025;288:114734. doi:10.1016/j.physbeh.2024.114734
Sarah E. Wolfensohn, Vera Baumans, F. Josef van der Staay, Saskia S. Arndt. Implications of stress for animal welfare and animal-based research†. Laboratory Animals. 2025:00236772251396310. doi:10.1177/00236772251396310
Vaishali Sahasrabudhe, Timothy Nicholas, Gianluca Nucci, Cynthia J Musante, Brian Corrigan. Impact of Model-Informed Drug Development on Drug Development Cycle Times and Clinical Trial Cost. Clinical Pharmacology & Therapeutics. 2025;118(2):378-385. doi:10.1002/cpt.3636
Manish Sharma, Mukta Nag, Gregory Q. Del Prete. Minimally Modified HIV-1 Infection of Macaques: Development, Utility, and Limitations of Current Models. Viruses. 2024;16(10):1618. doi:10.3390/v16101618
Lindsay J. Marshall, Kathleen M. Conlee. The case of the missing mouse—developing cystic fibrosis drugs without using animals. Frontiers in Drug Discovery. 2024;4. doi:10.3389/fddsv.2024.1347246